Here is a summary of results across the major trials
Tesamorelin is frequently examined in research involving growth hormone pathways, metabolic activity, body composition mechanisms, and peptide signaling
How is the medication delivered
Although originally developed for glycaemic control in type 2 diabetes, current authorisations now support its use for weight loss in adults with obesity or those overweight with weightrelated health conditions
Savings & Support, Boehringer Ingelheim Synjardy label, DailyMed (2025) Help with drug costs, Centers for Medicare & Medicaid Services Medication days supply, adherence, wastage, and cost among chronic patients in Medicaid, Medicare & Medicaid Research Review (2012) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
A., Tilley W